Artificial insemination market seen reaching $4.2 billion by 2033

By AI, Created 5:10 PM UTC, May 18, 2026, /AGP/ – Persistence Market Research says the global artificial insemination market will grow from an estimated $2.6 billion in 2026 to $4.2 billion by 2033. Growth is being driven by infertility treatment demand, livestock breeding programs and newer sperm processing technologies.

Why it matters: - Artificial insemination sits at the intersection of fertility care, livestock productivity and food security. - The market’s projected growth signals rising demand for reproductive health services and more intensive breeding programs in agriculture. - The segment also matters for sustainability efforts as producers try to improve output without expanding herd sizes as quickly.

What happened: - The global artificial insemination market is projected to rise from an estimated US$ 2.6 billion in 2026 to US$ 4.2 billion by 2033. - The forecast implies a 7.1% compound annual growth rate from 2026 to 2033. - The market is expanding across human fertility care and veterinary applications. - More information is available in the company’s sample report.

The details: - Rising infertility rates are a major demand driver. - Infertility affects roughly 17.5% of adults worldwide, or one in six people. - Government funding in Israel, Denmark and Australia has accelerated fertility treatment uptake. - Delayed parenthood in developed economies is sustaining demand for assisted reproductive solutions. - Intrauterine insemination is expected to lead procedures, with about 58% of revenue in 2026. - Intracervical insemination is projected to grow the fastest between 2026 and 2033. - AIH-husband is projected to account for about 70% of market revenue in 2026. - AIH-donor is expected to be the fastest-growing source type during the forecast period. - North America is expected to hold about 38% of market share in 2026. - Asia Pacific is projected to be the fastest-growing region through 2033. - Europe ranks as the second-largest regional market. - The market is moderately fragmented, with IMV Technologies, STgenetics, CooperSurgical, Select Sires Inc. and Genus plc collectively holding 35% to 40% of market share. - Key technologies include computer-assisted sperm analysis, advanced cryopreservation and genomic tools.

Between the lines: - The forecast reflects two separate but related markets: fertility treatment for humans and genetic improvement for livestock. - Public subsidies and insurance coverage can widen access, while high procedure costs still limit adoption in many places. - Regulatory and cultural differences continue to shape donor anonymity rules, semen storage standards and patient acceptance. - In livestock, tighter welfare rules in the European Union increase costs but also reinforce ethical standards. - Digital tools such as telemedicine, mobile apps and wearables are becoming part of the workflow, which can make treatment more efficient and personalized. - The market’s growth also points to broader use of genomics, embryo assessment and precision breeding in both human and animal applications.

What’s next: - Asia Pacific is likely to keep gaining share as fertility clinic networks expand and livestock programs scale up. - Clinics and suppliers are expected to keep investing in cryopreservation, digital monitoring and genomics-based tools. - Companies will also need to adapt to local rules and cost pressures through compliant facilities and partnerships. - The report highlights recent developments, including a Great Indian Bustard chick born via AI in Rajasthan in March 2026 and more than 200 AI centers announced for India by the Bill & Melinda Gates Foundation in February 2026. - The report also cites FAO training for veterinarians in Kyrgyzstan in August 2025 to improve livestock genetics and food security.

The bottom line: - Artificial insemination is moving from a niche procedure to a broader growth market in both healthcare and agriculture, with technology, public policy and breeding demand all pushing the business higher.